{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:47:44Z","timestamp":1793040464154,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.esmoop.2025.105293","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T04:53:21Z","timestamp":1749444801000},"page":"105293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Financial toxicity and socioeconomic impact of cancer in Europe"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2193-8391","authenticated-orcid":false,"given":"J.","family":"Vancoppenolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Franzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-081X","authenticated-orcid":false,"given":"L.","family":"Azarang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1055-503X","authenticated-orcid":false,"given":"T.","family":"Juslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Krini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7287-7683","authenticated-orcid":false,"given":"T.","family":"Lubbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9719-9110","authenticated-orcid":false,"given":"J.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4724-7871","authenticated-orcid":false,"given":"D.","family":"Mayeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-0960","authenticated-orcid":false,"given":"J.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Scotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Seoane L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Skaali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ubels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Retel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9580-0489","authenticated-orcid":false,"given":"W.H.","family":"van Harten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.esmoop.2025.105293_bib1","first-page":"409","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105293_bib2","first-page":"153","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105293_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-022-00341-1","article-title":"Financial toxicity: a common problem affecting patient care and health","volume":"8","author":"Pisu","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.esmoop.2025.105293_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100269","article-title":"Financial toxicity of cancer treatment: moving the discussion from acknowledgement of the problem to identifying solutions","volume":"20","author":"Desai","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105293_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw205","article-title":"Financial hardships experienced by cancer survivors: a systematic review","volume":"109","author":"Altice","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105293_bib6","first-page":"1131","article-title":"Coping mechanisms for financial toxicity: a qualitative study of cancer patients\u2019 experiences in Germany","volume":"28","author":"Schr\u00f6der","year":"2020","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105293_bib7","first-page":"349","article-title":"Patient-reported financial toxicity, quality of life, and health behaviors in insured US cancer survivors","volume":"29","author":"Ver Hoeve","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.esmoop.2025.105293_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.873556","article-title":"Challenges and opportunities with routinely collected data on the utilization of cancer medicines. Perspectives from health authority personnel across 18 European countries","volume":"13","author":"Pisana","year":"2022","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105293_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00066-022-01936-z","article-title":"Financial toxicity in cancer patients treated with radiotherapy in Germany-a cross-sectional study","volume":"198","author":"Fabian","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.esmoop.2025.105293_bib12","series-title":"Mapping Socio-economic Inequalities in Cancer Mortality Across European Countries","year":"2024"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105293_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12939-022-01765-7","article-title":"Health Equity Assessment Toolkit (HEAT and HEAT Plus): exploring inequalities in the COVID-19 pandemic era","volume":"21","author":"Kirkby","year":"2022","journal-title":"Int J Equity Health"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105293_bib15","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1016\/S1470-2045(23)00636-8","article-title":"The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions","volume":"25","author":"Schlander","year":"2024","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105293_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40271-023-00632-z","article-title":"Developing a conceptual framework for socioeconomic impact research in European cancer patients: a \u2018best-fit\u2019 framework synthesis","volume":"16","author":"Pham","year":"2023","journal-title":"Patient"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105293_bib17","first-page":"4241","article-title":"Understanding breast cancer survivors\u2019 financial burden and distress after financial assistance","volume":"28","author":"Semin","year":"2020","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105293_bib18","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/annonc\/mdw433","article-title":"The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy","volume":"27","author":"Perrone","year":"2016","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105293_bib19","first-page":"4477","article-title":"The validation of the Italian version of the COmprehensive Score for financial Toxicity (COST)","volume":"28","author":"Ripamonti","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.esmoop.2025.105293_bib20","series-title":"Financial toxicity","year":"2024"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105293_bib21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"14","author":"Luengo-Fernandez","year":"2013","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2025.105293_bib22","first-page":"4645","article-title":"Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review","volume":"28","author":"Longo","year":"2020","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105293_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.esmoop.2025.105293_bib24","series-title":"Towards a broader patients\u2019 perspective: the theory and practice of socioeconomic impact research","author":"Schlander","year":"2022"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105293_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12885-020-07028-4","article-title":"The patient-level effect of the cost of cancer care - financial burden in German cancer patients","volume":"20","author":"Mehlis","year":"2020","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105293_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 15","key":"10.1016\/j.esmoop.2025.105293_bib27","article-title":"Impact of out-of-pocket expenses on cancer care","volume":"29","author":"Zafar","year":"2011","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2025.105293_bib28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","article-title":"Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications","volume":"30","author":"Witte","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2025.105293_bib29","series-title":"An Introduction to EQ-5D Instruments and Their Applications","first-page":"1","article-title":"Methods for analysing and reporting EQ-5D data","author":"Devlin","year":"2020"},{"issue":"17","key":"10.1016\/j.esmoop.2025.105293_bib30","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1002\/cncr.33032","article-title":"Measuring financial toxicity incurred after treatment of head and neck cancer: development and validation of the Financial Index of Toxicity questionnaire","volume":"126","author":"Hueniken","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105293_bib32","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/curroncol28020117","article-title":"The out-of-pocket cost burden of cancer care-a systematic literature review","volume":"28","author":"Iragorri","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.esmoop.2025.105293_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.vhri.2017.08.001","article-title":"Drug policy in Bulgaria","volume":"13","author":"Dimova","year":"2017","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105293_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/jayao.2019.0051","article-title":"Age-related differences in financial toxicity and unmet resource needs among adolescent and young adult cancer patients","volume":"9","author":"Kaddas","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105293_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100521","article-title":"Short- and long-term impact of cancer on employment and financial outcomes of adolescents and young adults (AYAs): a large population-based case-control registry study in the Netherlands","volume":"7","author":"Janssen","year":"2022","journal-title":"ESMO Open"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105293_bib37","first-page":"7159","article-title":"Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis","volume":"30","author":"Donkor","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.esmoop.2025.105293_bib38","author":"Pousette"},{"key":"10.1016\/j.esmoop.2025.105293_bib40","series-title":"Free from cancer: achieving quality of life for all cancer patients and survivors","author":"Davies","year":"2025"},{"key":"10.1016\/j.esmoop.2025.105293_bib41","author":"Meunier"},{"key":"10.1016\/j.esmoop.2025.105293_bib42","author":"Janssen"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105293_bib43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/annonc\/mdv547","article-title":"Access to innovative oncology medicines in Europe","volume":"27","author":"Bergmann","year":"2016","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105293_bib44","first-page":"5693","article-title":"Financial toxicity and employment status in cancer survivors. A systematic literature review","volume":"28","author":"Mols","year":"2020","journal-title":"Support Care Cancer"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925011627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925011627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:44:17Z","timestamp":1762598657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702925011627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2059702925011627"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105293","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Financial toxicity and socioeconomic impact of cancer in Europe","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"105293"}}